Cours Cyteir Therapeutics, Inc.
Actions
CYTT
US23284P1030
Recherche biotechnologique et médicale
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
David Gaiero
DFI | Director of Finance/CFO | 45 | 01/12/20 |
Susan Doleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/19 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
John Thero
BRD | Director/Board Member | 63 | 04/02/22 |
Markus Renschler
CEO | Chief Executive Officer | 63 | 01/05/16 |
Jean George
BRD | Director/Board Member | 66 | 01/04/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,13 % | 43,43 Md | |
+48,83 % | 41,69 Md | |
+8,49 % | 41,31 Md | |
-10,82 % | 27,14 Md | |
+8,26 % | 25,28 Md | |
-23,69 % | 18,47 Md | |
+1,58 % | 12,33 Md | |
+32,83 % | 12,59 Md | |
+6,63 % | 11,03 Md |